Status:
COMPLETED
RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia
Lead Sponsor:
International Centre for Diarrhoeal Disease Research, Bangladesh
Conditions:
Treatment Failure
Lethargy
Eligibility:
All Genders
2-5 years
Phase:
NA
Brief Summary
Burden: Pneumonia remains the leading infectious cause of death accounting for 920,000 children under five around the world. This means a loss of over 2,500 child lives every day, or over 100 every ho...
Detailed Description
Severe pneumonia is a serious infection in children which requires timely intervention. Management of severe pneumonia is done by appropriate antibiotics and supportive care. WHO recommendation is to ...
Eligibility Criteria
Inclusion
- 1\. WHO classified severe pneumonia
Exclusion
- Very sick children require mechanical ventilation
- Children with any congenital or structural defect
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
308 Patients enrolled
Trial Details
Trial ID
NCT03369093
Start Date
January 1 2018
End Date
December 31 2019
Last Update
July 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dhaka Hospital, icddr,b
Dhaka, Bangladesh, 1212